Novel dual Src/Abl inhibitors for hematologic and solid malignancies. [electronic resource]
Producer: 20101025Description: 931-45 p. digitalISSN:- 1744-7658
- Aniline Compounds -- metabolism
- Animals
- Antineoplastic Agents -- pharmacology
- Benzodioxoles -- metabolism
- CSK Tyrosine-Protein Kinase
- Clinical Trials as Topic
- Dasatinib
- Dogs
- Drug Evaluation, Preclinical
- Fusion Proteins, bcr-abl -- antagonists & inhibitors
- Hematologic Neoplasms -- drug therapy
- Humans
- Mice
- Mice, Knockout
- Mice, Nude
- Mice, SCID
- Neoplasms -- drug therapy
- Nitriles -- metabolism
- Protein Kinase Inhibitors -- metabolism
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrimidines -- metabolism
- Quinazolines -- metabolism
- Quinolines -- metabolism
- Rats
- Thiazoles -- metabolism
- Triazines -- metabolism
- src-Family Kinases
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.